New pill aims to cut sickle cell pain crises
Disease control
Completed
This completed Phase 2 trial tested an oral drug called epeleuton in 35 adults with sickle cell disease. The goal was to see if it could reduce painful vaso-occlusive crises and improve blood cell health. Participants took 2000 mg capsules twice daily for 16 weeks, and researcher…
Phase: PHASE2 • Sponsor: Afimmune • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC